No More CR until FULL RESULTS are available and better, page-70

Love the definitive views Max!

• Time will indeed tell. Continuing good results in the absence of competition will ultimately make my case.

• BTW - Opportunity cost is the potential forgone profit from a missed opportunity (Investopedia) ie what you'd miss out on if you don't own it, and it receives a T/O offer or other uplift.

• An anecdotal example of another stock doesn't mean much tbh mate. Part of the reason why I like this stock is its potential for broad-spectrum and its novel approach, in addition to its track record. ie its not ''any'' bio.

• I was wondering whether we'd satisfy the "Future made in Australia" criteria this afternoon. Presumably a little too far from the current stated intent of the act, but equally likely too early tell today, Could it garner support as the legislative process continues. COVID is very high profile. I'd have someone look at it if I was MM. Might get look in under science or disaster areas? At any rate, the point is there a stated appetite for domestic business development & there's options for business out there that aren't CR or are not completely CR centric. Very saleable concept with results.